Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Mabs
|
May 21, 2026
Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3
Magali Genest, Dirk Van Lier, Theo Ikenna Uba, et al.
Plos One
|
June 6, 2012
Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice
Feriel Azibani, Yvan Devaux, Guillaume Coutance, et al.
International Journal of Cardiology
|
August 9, 2018
Reducing late maternal death due to cardiovascular disease - A pragmatic pilot study
Karen Sliwa, Feriel Azibani, Johann Baard, et al.
Experimental Hematology & Oncology
|
April 19, 2025
Anti-angiogenic tyrosine kinase inhibitors and the pathophysiology of their toxic effects: revisiting the treatment of anemia in metastatic cancers
Tai Van Nguyen, Eurydice Angeli, Diaddin Hamdan, et al.
Mabs
|
May 21, 2026
Preclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primates
Dirk van Lier, Magali Genest, Adrien Picod, et al.
Plos One
|
August 28, 2020
Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: A proof of concept study
Benjamin Deniau, Alice Blet, Karine Santos, et al.
ESC Heart Failure
|
March 16, 2026
Cardiac Biomarkers Response Under Angiotensin Receptor-Neprilysin Inhibitor: A Sub-Analysis of the Natrium-HF Study
Jolie Bruno, Aziz Daghmouri, Malha Sadoune, et al.
European Journal of Heart Failure
|
September 1, 2019
Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics
Benjamin Deniau, Linda Rehfeld, Karine Santos, et al.
ESC Heart Failure
|
February 18, 2020
Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers
Feriel Azibani, Tobias J Pfeffer, Melanie Ricke-Hoch, et al.
Experimental Hematology & Oncology
|
April 15, 2024
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
Eurydice Angeli, Justine Paris, Olivier Le Tilly, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Mabs
|
May 21, 2026
Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3
Magali Genest, Dirk Van Lier, Theo Ikenna Uba, et al.
Plos One
|
June 6, 2012
Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice
Feriel Azibani, Yvan Devaux, Guillaume Coutance, et al.
International Journal of Cardiology
|
August 9, 2018
Reducing late maternal death due to cardiovascular disease - A pragmatic pilot study
Karen Sliwa, Feriel Azibani, Johann Baard, et al.
Experimental Hematology & Oncology
|
April 19, 2025
Anti-angiogenic tyrosine kinase inhibitors and the pathophysiology of their toxic effects: revisiting the treatment of anemia in metastatic cancers
Tai Van Nguyen, Eurydice Angeli, Diaddin Hamdan, et al.
Mabs
|
May 21, 2026
Preclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primates
Dirk van Lier, Magali Genest, Adrien Picod, et al.
Plos One
|
August 28, 2020
Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: A proof of concept study
Benjamin Deniau, Alice Blet, Karine Santos, et al.
ESC Heart Failure
|
March 16, 2026
Cardiac Biomarkers Response Under Angiotensin Receptor-Neprilysin Inhibitor: A Sub-Analysis of the Natrium-HF Study
Jolie Bruno, Aziz Daghmouri, Malha Sadoune, et al.
European Journal of Heart Failure
|
September 1, 2019
Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics
Benjamin Deniau, Linda Rehfeld, Karine Santos, et al.
ESC Heart Failure
|
February 18, 2020
Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers
Feriel Azibani, Tobias J Pfeffer, Melanie Ricke-Hoch, et al.
Experimental Hematology & Oncology
|
April 15, 2024
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
Eurydice Angeli, Justine Paris, Olivier Le Tilly, et al.
Page
of 6